Synergistic effects of genetic variants of APOA5 and BTN2A1 on dyslipidemia or metabolic syndrome.
Hiramatsu M, Oguri M, Kato K, Horibe H, Fujimaki T, Watanabe S, Satoh K, Aoyagi Y, Tanaka M, Shin DJ, Lee JH, Jang Y, Yamada Y.
Hiramatsu M, et al. Among authors: jang y.
Int J Mol Med. 2012 Jul;30(1):185-92. doi: 10.3892/ijmm.2012.976. Epub 2012 Apr 20.
Int J Mol Med. 2012.
PMID: 22576629